LEWICKI JOHN A. (Chief Scientific Officer) exercised options at MEREO BIOPHARMA GROUP PLC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/25/2024ACC: 0000950170-24-077487
Officer· Chief Scientific Officer
Since Feb 2026
+138K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
138K acquired
Non-Derivative Transactions1
American Depositary Shares representing Ordinary Shares
Direct
Shares
+69K
Price / share
—
Trade value
—
% of position
1723.7%
6/21/2024
4K→73K
Total
Net shares
+69K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 6/21/2024 | M · Option Exercise | +69K | — | — | 1723.7% | 4K | 73K |
| Total | +69K | $0.00 | ||||||
Derivative Transactions1
Performance Based Restricted Stock Unit
Direct
Converts to
American Depository Shares
69K shares
Shares
+69K
Strike price
0
Held after
46K
Exercisable
—
6/21/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Based Restricted Stock Unit Direct | American Depository Shares69K shares | 6/21/2024 | M · Option Exercise | +69K | 0 | — | 46K |
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares representing Ordinary Shares
IndirectShares owned14.20K
Total
14.20K indirect14.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares representing Ordinary Shares | 14.20K | Indirect |
| Total | 14.20K | 14.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported